https://www.selleckchem.com/products/vx-561.html
ADAMTS9-AS2 controls the expression of RPL22 and thereby regulates TNBC malignancy the TGF-β signaling pathway. ADAMTS9-AS2 controls the expression of RPL22 and thereby regulates TNBC malignancy via the TGF-β signaling pathway.Increasing evidence reveals that breast cancer stem cells (BCSCs) subtypes with distinct properties are regulated by their abnormal metabolic changes; however, the specific molecular mechanism and its relationship with tumor microenvironment (TME) are not clear. In this study, we explored the mechanism of lactate d
Like
Comment
Share
